- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02052284
The Application of Sterile Water to the Skin of Extremely Low Birth Weight (ELBW) Infants
January 18, 2018 updated by: Mohamed ElDib, George Washington University
Extremely low birth weight infants have significant water loss through their skin immediately after birth.
This significant fluid loss is because they have large amounts of fluids, have immature skin and large surface area.
Loss of fluids is associated with many complications.
The investigators hypothesize that application of sterile water to the skin of these infants is associated with decreased fluid requirements in the first week of life , improve skin integrity and decrease some complications of prematurity.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Extremely low birth weight (ELBW) infants have significant transepidermal water loss immediately after birth.
This significant fluid loss is related to proportionally large extracellular pool of fluids, the immaturity of the skin barrier, and the relatively large surface area exposed to evaporation.
Water depletion in this population is associated with development of significant electrolyte imbalance in the form of hypernatremia, hyperkalemia, hyperglycemia and hyperosmolarity.
In order to compensate for these losses, clinicians have to progressively increase fluid intake.
Excessive fluid intake in the first days of life is associated with worsening patent ductus artriosus (PDA), necrotizing enterocolitis (NEC), bronchopulmonary dysplasia (BPD) and mortality.
Also skin integrity is important to protect against skin infection and secondary sepsis.
Based on recent studies and relevant data, the risk of sepsis in ELBW is up to 40% nationwide, but only about 25% at GWUH Water application is a benign treatment that is routinely applied to the skin of premature babies and was shown to decrease skin colonization.
The current practice at GWUH is to clean the bodies of premature infants using a piece of damp cloth with warm water.
This is performed at birth and consequently every other days.
The study group will receive more frequent and standardized applications.
The investigators hypothesize that application of sterile water in ELBW infants is associated with decreased fluid requirements in the first week of life.
As a secondary outcome, the investigators hypothesize that sterile water application is associated with improved skin integrity, decreased incidence of BPD with no increased incidence of skin or systemic infections.
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20037
- The George Washington University Hospital NICU
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 1 day (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Extremely Low Birth Weight (less than 1000 grams at birth), and
- Less than 24 hours of life
Exclusion Criteria:
- Major congenital anomalies
- Malformations or other surgical emergencies requiring immediate transfer.
- Major skin abnormalities
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
The control group will receive standard skin care of the NICU, which does not include specific measures to modulate skin-barrier function.The current practice at GWUH NICU is that nurses clean the bodies of newborns less than 1000 grams using a piece of damp cloth with warm water.
This is performed at birth and consequently every other days.
|
|
|
Experimental: Water wash
The study group will undergo a protocol of sterile water application in addition to routine skin care of the NICU.
The study group will receive more frequent and standardized applications.
A commercially sterile water bottle (Enfamil® Water) will be kept inside the isolette, to be maintained at isolette temperature, and will be changed on a daily basis.
Nurses use sterile gloves as a routine for care of ELBW infants.
A 2 inches x 2 inches sterile gauze will be soaked in sterile water and gently applied to all skin of the baby excluding umbilical cord and IV lines sites.
This procedure will be repeated every 4 hours with routine patient care for the first 1 week of life.
|
Nurses are trained in proper dispensing and application of water in a sterile gentle way that will minimize shear force on the skin, risk for skin injury, and the potential for spread of fecal flora.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Daily fluid intake (ml/kg/day)
Time Frame: First 7 days of life
|
The primary outcome is daily fluid requirements in the first week of life.
Daily fluid requirements from Day1 to Day7 will be compared between intervention and control groups.
|
First 7 days of life
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Skin Score
Time Frame: First 7 days of life
|
Neonatal Skin Condition Scale (NSCS) is a validated skin score used in the Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN) and the National Association of Neonatal Nurses (NANN) neonatal skin care evidence-based practice project.
Score ranges from 3 to 9, with 9 being the worse
|
First 7 days of life
|
|
Peak total bilirubin (mg/dl)
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 16 weeks
|
Participants will be followed for the duration of hospital stay, an expected average of 16 weeks
|
|
|
Incidence of significant PDA
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 16 weeks
|
Defined as PDA requiring treatment either medical or surgical
|
Participants will be followed for the duration of hospital stay, an expected average of 16 weeks
|
|
Incidence of NEC
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 16 weeks
|
Necrotizing Enterocolitis (NEC): defined as stages II or III
|
Participants will be followed for the duration of hospital stay, an expected average of 16 weeks
|
|
Incidence of BPD
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 16 weeks
|
Bronchopulmonary dysplasia (BPD), defined as O2 requirement at 36 weeks post menstrual age (PMA)
|
Participants will be followed for the duration of hospital stay, an expected average of 16 weeks
|
|
Length of stay (days)
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 16 weeks
|
Participants will be followed for the duration of hospital stay, an expected average of 16 weeks
|
|
|
Incidence of culture proved sepsis
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 16 weeks
|
Culture proved sepsis
|
Participants will be followed for the duration of hospital stay, an expected average of 16 weeks
|
|
Incidence of change in microbiological skin colonization
Time Frame: First week of life
|
Change in microbiological skin colonization by skin swab between day one and day 7 of life.
|
First week of life
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Mohamed El-Dib, MD, The George Washington University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Baumgart S, Langman CB, Sosulski R, Fox WW, Polin RA. Fluid, electrolyte, and glucose maintenance in the very low birth weight infant. Clin Pediatr (Phila). 1982 Apr;21(4):199-206. doi: 10.1177/000992288202100401.
- Afsar FS. Physiological skin conditions of preterm and term neonates. Clin Exp Dermatol. 2010 Jun;35(4):346-50. doi: 10.1111/j.1365-2230.2009.03562.x. Epub 2009 Sep 15.
- Bell EF, Acarregui MJ. Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2008 Jan 23;(1):CD000503. doi: 10.1002/14651858.CD000503.pub2.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2014
Primary Completion (Actual)
December 1, 2017
Study Completion (Actual)
December 31, 2017
Study Registration Dates
First Submitted
January 24, 2014
First Submitted That Met QC Criteria
January 31, 2014
First Posted (Estimate)
February 3, 2014
Study Record Updates
Last Update Posted (Actual)
January 23, 2018
Last Update Submitted That Met QC Criteria
January 18, 2018
Last Verified
January 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 071319
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dehydration
-
United States Army Research Institute of Environmental...CompletedDehydration Hypertonic | Isotonic Dehydration
-
University of HartfordArizona State University; Kraft Heinz CompanyCompletedDehydration in Children | Dehydration Following Exertion (Disorder)United States
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...UnknownAged | Dehydration HypertonicItaly
-
University of DelawareNational Heart, Lung, and Blood Institute (NHLBI); National Institute of General...Completed
-
Rhode Island HospitalInternational Centre for Diarrhoeal Disease Research, Bangladesh; Fogarty International...Completed
-
Wayne State UniversityUniversity of ChicagoUnknown
-
University College, LondonUniversity of Portsmouth; University of WollongongUnknownDehydration HypertonicUnited Kingdom
-
University of North Carolina, GreensboroNot yet recruitingWater Stress | Body Water DehydrationUnited States
-
Arizona State UniversityKraft Heinz CompanyCompleted
-
Children's Hospital Los Angeles410 Medical; Atlanta Pediatric Device ConsortiumCompletedDehydration in Children | DehydrationUnited States
Clinical Trials on Sterile water application
-
Milton S. Hershey Medical CenterChildren's Miracle NetworkCompletedVery Low Birth Weight InfantsUnited States
-
University Tunis El ManarActive, not recruiting
-
Woman's Health University Hospital, EgyptUnknown
-
Nadja Haiden,MDCompletedMeconium Ileus | Very Low Birth Weight Infant
-
Changi General HospitalUnknownTracheostomy ComplicationSingapore
-
Case Western Reserve UniversityCompletedHypernatremia | Extremely Low Birth Weight InfantsUnited States
-
TC Erciyes UniversityRecruitingSleep Disorder | Restless Legs Syndrome | PregnantTurkey
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompleted
-
Universidad Nacional Autonoma de MexicoHospital General de MexicoUnknownRespiratory Infections in ChildrenMexico